These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 33198317)

  • 21. PPARs and Microbiota in Skeletal Muscle Health and Wasting.
    Manickam R; Duszka K; Wahli W
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome Proliferator-activated Receptors as Potential Targets for Carcinogenic Activity of Polychlorinated Biphenyls: A Computational Perspective.
    Sheikh IA; Khweek AA; Beg MA
    Anticancer Res; 2016 Nov; 36(11):6117-6124. PubMed ID: 27793940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [PPARs-mediated intracellular signal transduction].
    Fujii H
    Nihon Rinsho; 2005 Apr; 63(4):565-71. PubMed ID: 15828221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of feeding regimens on circadian rhythms: implications for aging and longevity.
    Froy O; Miskin R
    Aging (Albany NY); 2010 Dec; 2(1):7-27. PubMed ID: 20228939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
    Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future Perspectives.
    Laganà AS; Vitale SG; Nigro A; Sofo V; Salmeri FM; Rossetti P; Rapisarda AM; La Vignera S; Condorelli RA; Rizzo G; Buscema M
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interaction between the renin-angiotensin system and peroxisome proliferator activated receptors: a hypothesis including the participation of mitochondria in aging.
    de Cavanagh EM; Piotrkowski B; Fraga CG
    Front Biosci; 2007 Jan; 12():1049-62. PubMed ID: 17127360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
    Gervois P; Fruchart JC; Staels B
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPAR expression throughout the oestrous cycle in the bovine endometrium.
    Socha BM; Łupicka M; Szczepańska AA; Korzekwa AJ
    Theriogenology; 2017 Sep; 100():88-94. PubMed ID: 28708539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-lived alphaMUPA transgenic mice exhibit pronounced circadian rhythms.
    Froy O; Chapnik N; Miskin R
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1017-24. PubMed ID: 16787960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic Aspects of Aging.
    Fridell YW; Sierra F
    Prog Mol Biol Transl Sci; 2018; 155():11-23. PubMed ID: 29653679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection.
    Barlaka E; Galatou E; Mellidis K; Ravingerova T; Lazou A
    Cardiovasc Ther; 2016 Feb; 34(1):37-48. PubMed ID: 26589375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis-Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the Kynurenines.
    Fakan B; Szalardy L; Vecsei L
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPARs and angiogenesis.
    Bishop-Bailey D
    Biochem Soc Trans; 2011 Dec; 39(6):1601-5. PubMed ID: 22103494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circadian regulation of the hepatic endobiotic and xenobitoic detoxification pathways: the time matters.
    Zmrzljak UP; Rozman D
    Chem Res Toxicol; 2012 Apr; 25(4):811-24. PubMed ID: 22303888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PPARs and Myocardial Infarction.
    Wagner KD; Wagner N
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circadian clocks govern calorie restriction-mediated life span extension through BMAL1- and IGF-1-dependent mechanisms.
    Patel SA; Chaudhari A; Gupta R; Velingkaar N; Kondratov RV
    FASEB J; 2016 Apr; 30(4):1634-42. PubMed ID: 26700733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPARs at the crossroads of lipid signaling and inflammation.
    Wahli W; Michalik L
    Trends Endocrinol Metab; 2012 Jul; 23(7):351-63. PubMed ID: 22704720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-meal caloric restriction induces 12-hour rhythms and improves glucose homeostasis.
    Velingkaar N; Mezhnina V; Poe A; Kondratov RV
    FASEB J; 2021 Feb; 35(2):e21342. PubMed ID: 33543540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interrelations among feeding, circadian rhythms and ageing.
    Froy O; Miskin R
    Prog Neurobiol; 2007 Jun; 82(3):142-50. PubMed ID: 17482337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.